12.28MMarket Cap
0.03P/E TTM
Tempest Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Tempest Therapeutics Inc is 8.64, ranking 77 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.03, which is 143.98% below the recent high of 0.06 and 217420.30% above the recent low of -57.81.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.